Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Aug 28, 2025 3:59:58 PM EDT

207.90USD-0.077%(-0.16)4,517,364

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 25, 2025 9:27:30 AM EDT

211.02USD+1.424%(+2.96)0

After-hours

Aug 28, 2025 4:26:30 PM EDT

207.30USD-0.289%(-0.60)306,942

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

367.36B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Next Earnings

Oct 28, 2025 (60d)

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

4,570,739

Avg. Vol. 30 Day

4,823,148

Employees

30,000

Market Cap

367,355,788,711

Shares Out.

1,766,558,253

On/Off Exchange

53%/47%

6 Month Beta

0.52

1 Year Beta

0.41

2 Year Beta

0.38

3 Year Beta

0.36

52 Week Low

163.81

52 Week High

218.66

SMA50

194.05

SMA200

188.75

1 Week

-0.74%

1 Month

+10.31%

3 Month

+13.58%

6 Month

-0.52%

1 Year

+6.42%

2 Year

+41.05%

5 Year

+120.82%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $207.90, and today's volume is 4,517,364. ABBV is down -0.077% today. The 30 day average volume is 4,823,148. ABBV market cap is 367.36B with 1,766,558,253 shares outstanding.

document.getElementById("Q6lTPr").onerror = function(){this.style.display='none';}; .dark-mode .JVWTnK{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .JVWTnK{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE